Immunogenicity and protective efficacy in mice of influenza B virus vaccines grown in mammalian cells or embryonated chicken eggs

Journal of Virology

Volumn 72, Issue 5, 1998, Pages 4472-4477

  Alymova, I V ^a,b   Kodihalli, S ^a   Govorkova, E A ^a,b   Fanget, B ^c   Gerdil, C ^c   Webster, R G ^a,d  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b D I IVANOVSKY INSTITUTE OF VIROLOGY   (Russian Federation)

^c Dept of Pharmaceutical Development ^*  (France)

^d UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA B VIRUS VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHICK EMBRYO; DRUG EFFICACY; EMBRYO; GROWTH STIMULATION; IMMUNIZATION; IMMUNOGENICITY; IMMUNOGLOBULIN PRODUCING CELL; INFLUENZA VIRUS B; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; VACCINATION;

EID: 0031967892     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.5.4472-4477.1998     Document Type: Article

References (36)

1. Allan, W., Z. Tabi, A. Cleary, and P. C. Doherty. 1990. Cellular events in the lymph node and lung of mice with influenza. Consequences of depleting CD4+ T cells. J. Immunol. 144:3980-3986.
2. Al-Shakhshir, R., F. Regnier, J. L. White, and S. L. Hem. 1994. Effect of protein adsorption on the surface charge characteristics of aluminum-containing adjuvants. Vaccine 12:472-474.
3. Aymard, M., L. Gerentes, M. Valette, J. Million-Jolly, B. Lina, N. Kessler, A. Douglas, K. Cameron, and A. J. Hay. 1996. Variation of neuraminidase activity of influenza A H3N2 viruses isolated in MDCK cells, p. 485-490. In Options for the control of influenza III: Proceedings of the Third International Conference on Options for the Control of Influenza. Elsevier, Amsterdam, The Netherlands.
4. Caton, A. J., G. G. Brownlee, J. W. Yewdel, and W. Gerhard. 1982. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 31:417-427.
5. Couch, R. B., R. G. Douglas, Jr., D. S. Fedson, and J. A. Kasel. 1971. Correlated studies of recombinant influenza virus vaccine. III. Protection against experimental influenza in man. J. Infect. Dis. 124:473-480.
6. Czerkinsky, C. C., L. A. Nilsson, H. Nygren, O. Ouchterlony, and A. Tarknowski. 1983. A solid-phase enzyme-linked immunospot (ELISPOT) assay for the enumeration of specific antibody-secreting cells. J. Immunol. Methods 65:109-121.
7. Gerhard, W., A. M. Haberman, P. A. Scherle, A. H. Taylor, G. Palladino, and A. J. Caton. 1991. Identification of eight determinants in the hemagglutinin molecule of influenza virus A/PR/8/34 (H1N1) which are recognized by class II-restricted T cells from BALB/c mice. J. Virol. 65:364-372.
8. Govorkova, E. A., N. V. Kaverin, L. V. Gubareva, B. Meignier, and R. G. Webster. 1995. Replication of influenza A viruses in a green monkey kidney continuous cell line (Vero). J. Infect. Dis. 172:250-253.
9. Johansson, B. E., D. J. Bucher, and E. D. Kilbourne. 1989. Purified influenza virus hemagglutinin and neuraminidase are equivalent in stimulation of antibody response but induce contrasting types of immunity to infection. J. Virol. 63:1239-1246.
10. Johansson, B. E., and E. D. Kilbourne. 1993. Dissociation of influenza virus hemagglutinin and neuraminidase eliminates their intravirionic antigenic competition. S. Virol. 67:5721-5723.
11. Johansson, B. E., and E. D. Kilbourne. 1994. Immunization with purified N1 and N2 influenza virus neuraminidase demonstrates cross-reactivity without antigenic competition. Proc. Natl. Acad. Sci. USA 19:2358-2361.
12. Katz, J. M., C. W. Naeve, and R. G. Webster. 1987. Host cell-mediated variation in H3N2 influenza viruses. Virology 156:386-395.
13. Katz, J. M., M. Wang, and R. G. Webster. 1990. Direct sequencing of the HA gene of influenza (H3N2) virus in original clinical samples reveals identity with mammalian cell-grown virus. J. Virol. 64:1808-1811.
14. Katz, J. M., and R. G. Webster. 1989. Efficacy of inactivated influenza A virus (H3N2) vaccines grown in mammalian cells or embryonated eggs. J. Infect. Dis. 160:191-198.
15. Katz, J. M., and R. G. Webster. 1992. Amino acid sequence identity between the HA1 of influenza A (H3N2) viruses grown in mammalian and primary chick kidney cells. J. Gen. Virol. 73:1159-1165.
16. Kilbourne, E. D., C. P. Cerini, M. W. Khan, J. W. Mitchell, Jr., and P. O. Ogra. 1987. Immunologic response to the influenza neuraminidase is influenced by prior experience with the associated viral hemagglutinin. I. Studies in human vaccinees. J. Immunol. 138:3010-3013.
17. Kodihalli, S., D. Justewicz, L. V. Gubareva, and R. G. Webster. 1995. Selection of a single amino acid substitution in the hemagglutinin molecule by chicken eggs can render influenza A virus (H3) candidate vaccine ineffective. J. Virol. 69:4888-4897.
18. Krystal, M., R. M. Elliott, E. W. Benz, Jr., J. F. Young, and P. Palese. 1982. Evolution of influenza A and B viruses: conservation of structural features in the hemagglutinin genes. Proc. Natl. Acad. Sci. USA 79:4800-4804.
19. Liang, S., K. Mozdzanowska, G. Palladino, and W. Gerhard. 1994. Heterosubtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity. J. Immunol. 152:1653-1661.
20. Montagnon, B. J., B. Fanget, and A. J. Nicolas. 1981. The large-scale cultivation of Vero cells in microcarrier culture for virus vaccine production. Preliminary results for killed poliovirus vaccine. Dev. Biol. Stand. 64:47-55.
21. Oxford, J. S., G. C. Schild, T. Corcoran, R. Newman, D. Major, J. Robertson, J. Bootman, P. Higgins, W. Al-Nakib, and D. A. J. Tyrrel. 1990. A host-cell-selected variant of influenza B virus with a single nucleotide substitution in HA affecting a potential glycosylation site was attenuated in virulence for volunteers. Arch. Virol. 110:37-46.
22. Palache, A. M., R. Brands, and G. J. M. van Scharrenburg. 1997. Immunogenicity and reactogenicity of influenza subunit vaccines produced in MDCK cells or fertilized chicken eggs. J. Infect. Dis. 176:520-523.
23. Robertson, J. S., J. S. Bootman, R. Newman, J. S. Oxford, R. S. Daniels, R. G. Webster, and G. C. Schild. 1987. Structural changes in the hemagglutinin which accompany egg adaptation of an influenza A (H1N1) virus. Virology 160:31-37.
24. Robertson, J. S., J. S. Bootman, C. Nicolson, D. Major, E. W. Robertson, and J. M. Wood. 1990. The hemagglutinin of influenza B virus present in clinical material is a single species identical to that of mammalian cell-grown virus. Virology 179:35-40.
25. Robertson, J. S., C. W. Naeve, R. G. Webster, J. S. Bootman, R. Newman, and G. C. Schild. 1985. Alterations in the hemagglutinin associated with adaptation of influenza B virus to growth in eggs. Virology 143:166-174.
26. Robertson, J. S., C. Nicolson, J. S. Bootman, D. Major, E. W. Robertson, and J. M. Wood. 1991. Sequence analysis of the haemagglutinin (HA) of influenza A (H1N1) viruses present in clinical material and comparison with the HA of laboratory-derived virus. J. Gen. Virol. 72:2671-2677.
27. Rota, P. A., M. W. Shaw, and A. P. Kendal. 1987. Comparison of the immune response to variant influenza type B hemagglutinins expressed in vaccinia virus. Virology 161:269-275.
28. Rota, P. A., M. W. Shaw, and A. P. Kendal. 1989. Cross-protection against microvariants of influenza virus type B by vaccinia viruses expressing haemagglutinins from egg-or MDCK cell-derived subpopulations of influenza virus type B/England/222/82. J. Gen. Virol. 70:1533-1537.
29. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467.
30. Sprent, J. 1994. T and B memory cells. Cell 76:315-322.
31. Verhoeyen, M., L. Van Rompuy, W. M. Jou, D. Huylebroeck, and W. Fiers. 1983. Complete nucleotide sequence of the influenza B/Singapore/222/79 virus hemagglutinin gene and comparison with B/Lee/40 hemagglutinin. Nucleic Acids Res. 11:4703-4712.
32. Wang, Y., J. A. Smith, M. L. Gefter, and D. L. Perkins. 1992. Immunodominance: intermolecular competition between MHC class II molecules by covalently linked T cell epitopes. J. Immunol. 148:3034-3041.
33. Warner, T. G., and J. S. O'Brien. 1979. Synthesis of 2'-(4-methylumbelliferyl)-α-D-N-acetylneuraminic acid and detection of skin fibroblast neuraminidase in normal humans and in sialidosis. Biochemistry 18:2783-2787.
34. Warren, L. J. 1959. The thiobarbituric acid assay of sialic acids. J. Biol. Chem. 234:1971-1975.
35. Wood, J. M., J. S. Oxford, U. Dunleavy, R. W. Newman, D. Major, and J. S. Robertson. 1989. Influenza A (H1N1) vaccine efficacy in animal models is influenced by two ammo-acid substitutions in the hemagglutinin molecule. Virology 171:214-221.
36. Zuckerman, M. A., R. J. Cox, and J. S. Oxford. 1994. Attenuation of virulence in influenza B viral infection of volunteers. J. Infect. Dis. 28:41-48.